1. Home
  2. MRSN vs AMPG Comparison

MRSN vs AMPG Comparison

Compare MRSN & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • AMPG
  • Stock Information
  • Founded
  • MRSN 2001
  • AMPG 2002
  • Country
  • MRSN United States
  • AMPG United States
  • Employees
  • MRSN N/A
  • AMPG N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • AMPG Telecommunications Equipment
  • Sector
  • MRSN Health Care
  • AMPG Telecommunications
  • Exchange
  • MRSN Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • MRSN 40.7M
  • AMPG 46.7M
  • IPO Year
  • MRSN 2017
  • AMPG N/A
  • Fundamental
  • Price
  • MRSN $0.36
  • AMPG $2.00
  • Analyst Decision
  • MRSN Strong Buy
  • AMPG Strong Buy
  • Analyst Count
  • MRSN 5
  • AMPG 1
  • Target Price
  • MRSN $5.75
  • AMPG $5.00
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • AMPG 261.5K
  • Earning Date
  • MRSN 08-12-2025
  • AMPG 08-13-2025
  • Dividend Yield
  • MRSN N/A
  • AMPG N/A
  • EPS Growth
  • MRSN N/A
  • AMPG N/A
  • EPS
  • MRSN N/A
  • AMPG N/A
  • Revenue
  • MRSN $34,006,000.00
  • AMPG $10,814,140.00
  • Revenue This Year
  • MRSN N/A
  • AMPG $114.55
  • Revenue Next Year
  • MRSN $1.30
  • AMPG $50.00
  • P/E Ratio
  • MRSN N/A
  • AMPG N/A
  • Revenue Growth
  • MRSN N/A
  • AMPG N/A
  • 52 Week Low
  • MRSN $0.26
  • AMPG $0.64
  • 52 Week High
  • MRSN $2.83
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 46.82
  • AMPG 46.09
  • Support Level
  • MRSN $0.35
  • AMPG $1.96
  • Resistance Level
  • MRSN $0.39
  • AMPG $2.40
  • Average True Range (ATR)
  • MRSN 0.03
  • AMPG 0.12
  • MACD
  • MRSN -0.00
  • AMPG -0.05
  • Stochastic Oscillator
  • MRSN 12.30
  • AMPG 9.09

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: